Determining the Impact of Shunting and CerebroVascular Reactivity on 7T MRI (DISCoVeR 7T MRI)
Status: | Recruiting |
---|---|
Conditions: | Cognitive Studies, Cognitive Studies |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 60 - Any |
Updated: | 11/30/2018 |
Start Date: | October 26, 2017 |
End Date: | October 2019 |
Contact: | Nichole Gallatti |
Email: | nichole.gallatti@uphs.upenn.edu |
Phone: | 2153498651 |
A Pilot Cross-sectional Cohort Study of Right-to-left-shunt, Cerebrovascular Reactivity, Ischemic Infarct Burden on High Resolution MRI, and Cognitive Impairment in Elderly Subjects
The purpose of this study is to use transcanial doppler (TCD) ultrasound to look for possible
risk factors for ischemic brain injury. We will perform contrast TCD with agitated saline
contrast to identify and contrast right-to-left shunt (RLS) and breath holding to assess
cerebrovascular reactivity (CVR) in the elderly.
risk factors for ischemic brain injury. We will perform contrast TCD with agitated saline
contrast to identify and contrast right-to-left shunt (RLS) and breath holding to assess
cerebrovascular reactivity (CVR) in the elderly.
Inclusion Criteria:
1. Males and females ≥ 60 years of age.
2. Fluent in English.
3. Part of the NACC longitudinal cohort (Protocol #: 068200) of the PMC/ADCC with
consensus conference designation of cognitively normal, Mild Cognitive Impairment, or
probable/possible Alzheimer's disease.
4. Has consented to participate in the ADCC high-resolution MRI sub-study.
5. NACC longitudinal visit must be within 6 months of the TCD study and brain MRI study.
6. Women: post-menopausal or surgically sterile.
7. Willing and able to complete all required study procedures.
8. Completed 6 grades of education.
9. Geriatric Depression scale less than 6 (assessed within 6 months at the NACC
longitudinal visit).
Exclusion Criteria:
1. Prior clinically symptomatic ischemic or hemorrhagic stroke.
2. Inability to tolerate or contraindication to TCD study in the opinion of an
investigator or treating physician.
3. Any medical or psychological conditions that, in the opinion of the investigator,
would compromise the subject's safety or successful participation in the study.
We found this trial at
1
site
3400 Spruce St
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-4000
Principal Investigator: Steven R Messe, M.D
Phone: 215-349-8651
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
Click here to add this to my saved trials